Replimune Group (REPL) News Today $5.40 +0.02 (+0.37%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$5.40 -0.01 (-0.09%) As of 08/29/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why Is Replimune Group Up Today?Toggle Visibility of Why Is Replimune Group Up Today?Replimune Group, Inc. (NASDAQ: REPL) shares are trading lower today after a wave of notices and filings from multiple law firms alerting investors to a proposed securities class action and the approaching September 22, 2025 lead‐plaintiff deadline. Below are the recent developments: Negative Sentiment: Faruqi & Faruqi, LLP reminds investors of the pending federal securities class action against Replimune and urges those who suffered losses over $50,000 between November 22, 2024 and July 21, 2025 to contact the firm before the September 22, 2025 lead‐plaintiff deadline. Faruqi & Faruqi Reminder Negative Sentiment: Kessler Topaz Meltzer & Check, LLP notifies shareholders that a securities fraud class action has been filed on behalf of those who acquired REPL securities between November 22, 2024 and July 21, 2025, with September 22, 2025 as the deadline to seek lead‐plaintiff status. Kessler Topaz Reminder Negative Sentiment: Levi & Korsinsky, LLP files a class action seeking recovery for investors who purchased REPL shares during the class period, and provides contact information for those interested in joining the lawsuit. Levi & Korsinsky Filing Negative Sentiment: Rosen Law Firm, a top‐ranked investor rights firm, encourages Replimune purchasers to secure counsel before the September 22, 2025 deadline in the securities class action first filed by the firm. Rosen Law Firm Notice Negative Sentiment: Levi & Korsinsky notifies REPL shareholders of the class action suit and the September 22, 2025 deadline to participate. Levi & Korsinsky Notice Negative Sentiment: Robbins LLP reminds investors with sizable losses to contact the firm for information on the pending lead‐plaintiff deadline in the Replimune class action. Robbins LLP Reminder Negative Sentiment: Faruqi & Faruqi issues a shareholder notice investigating claims on behalf of Replimune investors and urges those with losses over $50,000 to reach out. Faruqi & Faruqi Notice Negative Sentiment: Levi & Korsinsky, LLP notifies investors via GlobeNewswire of the class action seeking recovery for those who acquired Replimune securities between November 22, 2024 and July 21, 2025. Levi & Korsinsky GlobeNewswire Negative Sentiment: Bronstein, Gewirtz & Grossman LLC alerts investors that those with substantial losses may have an opportunity to lead the class action against Replimune. Bronstein Alert Negative Sentiment: Levi & Korsinsky advises investors to contact the firm before September 22, 2025 to discuss their rights in the Replimune class action. Investor Rights Notice Negative Sentiment: The Gross Law Firm notifies shareholders that Replimune has been sued for securities law violations and encourages them to contact the firm for more information. Gross Law Firm Notice Posted 1+ days agoAI Generated. May Contain Errors. REPL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Kessler Topaz Meltzer & Check, LLP Encourages Replimune Group, Inc. Investors With Losses to Contact the FirmAugust 31 at 2:08 AM | theglobeandmail.comROSEN, A LONGSTANDING FIRM, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - REPLAugust 31 at 2:50 AM | markets.businessinsider.comReplimune Group, Inc. $REPL Shares Sold by Wellington Management Group LLPAugust 30 at 4:13 AM | marketbeat.comFaruqi & Faruqi Reminds Replimune Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 22, 2025 - REPLAugust 29 at 11:10 AM | prnewswire.comREPL Class Action Lawsuit Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Replimune Group, Inc. (REPL) Investors that a Securities Fraud Class Action Lawsuit Has Been FiledAugust 29 at 7:56 AM | globenewswire.comVanguard Group Inc. Increases Stock Position in Replimune Group, Inc. $REPLAugust 29 at 3:14 AM | marketbeat.comClass Action Filed Against Replimune Group, Inc. (REPL) Seeking Recovery for Investors - Contact Levi & KorsinskyAugust 29 at 2:31 AM | theglobeandmail.comROSEN, A TOP RANKED LAW FIRM, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – REPLAugust 28 at 10:31 PM | globenewswire.comLevi & Korsinsky Notifies Replimune Group, Inc. (REPL) Shareholders of Class Action Lawsuit and September 22, 2025 DeadlineAugust 28 at 9:30 PM | theglobeandmail.comREPL Class Action Reminder: Investors with Large Losses Should Contact Robbins LLP for Information About the Pending Lead Plaintiff Deadline in the Replimune Group, Inc. Class Action LawsuitAugust 28 at 8:20 PM | prnewswire.comSHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ReplimuneAugust 28 at 8:17 PM | globenewswire.comClass Action Filed Against Replimune Group, Inc. (REPL) Seeking Recovery for Investors – Contact Levi & KorsinskyAugust 28 at 4:42 PM | globenewswire.comREPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Replimune Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitAugust 28 at 4:00 PM | globenewswire.comInvestors in Replimune Group, Inc. Should Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - REPLAugust 28 at 11:27 AM | theglobeandmail.comReplimune Group, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - REPLAugust 28 at 8:45 AM | prnewswire.comPrice T Rowe Associates Inc. MD Sells 109,051 Shares of Replimune Group, Inc. $REPLAugust 28 at 5:06 AM | marketbeat.comREPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit First Filed by The Rosen Law FirmAugust 27, 2025 | prnewswire.comSeptember 22, 2025 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against REPLAugust 27, 2025 | globenewswire.comKirby McInerney LLP Reminds Replimune Group, Inc. Investors of Class Action Filing and Encourages Investors to Contact the FirmAugust 27, 2025 | globenewswire.comReplimune (REPL) Faces Investor Lawsuit Following 77% Stock Crash After FDA Rejects Key Drug - Hagens BermanAugust 27, 2025 | globenewswire.comNuveen LLC Acquires Shares of 671,411 Replimune Group, Inc. $REPLAugust 27, 2025 | marketbeat.comReplimune Group, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - REPLAugust 26, 2025 | prnewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - REPLAugust 25, 2025 | prnewswire.comKessler Topaz Meltzer & Check, LLP Reminds Replimune Group, Inc. Investors of Important Deadline in Securities Fraud Class Action LawsuitAugust 25, 2025 | theglobeandmail.comReplimune (REPL) Faces Investor Lawsuit Following 77% Stock Crash After FDA Rejects Key Drug - Hagens BermanAugust 25, 2025 | globenewswire.comROSEN, THE FIRST FILING FIRM, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – REPLAugust 25, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPLAugust 25, 2025 | globenewswire.comClass Action Filed Against Replimune Group, Inc. (REPL) Seeking Recovery for Investors - Contact The Gross Law FirmAugust 25, 2025 | prnewswire.comSHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Replimune Group, Inc. (NASDAQ: REPL)August 25, 2025 | globenewswire.comROSEN, LEADING TRIAL COUNSEL, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - REPLAugust 24, 2025 | markets.businessinsider.comClass Action Announcement for Replimune Group, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against Replimune Group, Inc. - Contact Kessler Topaz Meltzer ...August 23, 2025 | theglobeandmail.comROSEN, NATIONAL INVESTOR RIGHTS COUNSEL, Encourages Replimune Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – REPLAugust 22, 2025 | globenewswire.comREPL Investors Have Opportunity to Lead Replimune Group, Inc. Securities Lawsuit First Filed by The Rosen Law FirmAugust 22, 2025 | prnewswire.comLost Money on Replimune Group, Inc.(REPL)? Join Class Action Suit Seeking Recovery – Contact Levi & KorsinskyAugust 22, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - REPLAugust 22, 2025 | prnewswire.comShareholders that lost money on Replimune Group, Inc.(REPL) should contact Levi & Korsinsky about pending Class Action - REPLAugust 22, 2025 | prnewswire.comInsider Selling: Replimune Group (NASDAQ:REPL) CFO Sells 9,154 Shares of StockAugust 21, 2025 | marketbeat.comREPL INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Replimune Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitAugust 21, 2025 | globenewswire.comClass Action Filed Against Replimune Group, Inc. (REPL) Seeking Recovery for Investors – Contact The Gross Law FirmAugust 21, 2025 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPLAugust 21, 2025 | globenewswire.comSHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of ReplimuneAugust 21, 2025 | prnewswire.comReplimune Group, Inc. (REPL) Investors: September 22, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLPAugust 20, 2025 | theglobeandmail.comInvestors in Replimune Group, Inc. (REPL): Protect Your Rights - Contact Levi & Korsinsky Before September 22, 2025August 20, 2025 | theglobeandmail.comInvestors Who Lost Money on Replimune Group, Inc. (REPL) Should Contact Levi & Korsinsky About Pending Class Action - REPLAugust 20, 2025 | theglobeandmail.comREPL Investors Have the Opportunity to Lead the Replimune Securities Fraud Lawsuit with Faruqi & Faruqi, LLPAugust 20, 2025 | globenewswire.comReplimune (REPL) Faces Securities Class Action Following Stock's Collapse Amid FDA's Rejection of Melanoma Drug – Hagens BermanAugust 20, 2025 | globenewswire.comShareholders of Replimune Group, Inc. Should Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights – REPLAugust 19, 2025 | globenewswire.comClass Action Filed Against Replimune Group, Inc. ...August 19, 2025 | gurufocus.comClass Action Filed Against Replimune Group, Inc. (REPL) - September 22, 2025 Deadline to Join - Contact Levi & KorsinskyAugust 19, 2025 | prnewswire.comReplimune Group, Inc. Class Action: The Gross Law Firm Reminds Replimune Group, Inc. ...August 18, 2025 | gurufocus.com Get Replimune Group News Delivered to You Automatically Sign up to receive the latest news and ratings for REPL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. REPL Media Mentions By Week REPL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. REPL News Sentiment▼0.331.09▲Average Medical News Sentiment REPL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. REPL Articles This Week▼308▲REPL Articles Average Week Get the Latest News and Ratings for REPL and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Replimune Group and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Apogee Therapeutics News Beam Therapeutics News Immunocore News Cidara Therapeutics News Aurinia Pharmaceuticals News Biohaven News WAVE Life Sciences News Travere Therapeutics News Tilray Brands News Edgewise Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:REPL) was last updated on 8/31/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Replimune Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Replimune Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free REPL Stock Alerts